KA Kreuzer, P le Coutre. Re: Lange T et al. Quantitative reverse transcription polymerase chain reaction should not replace conventional cytogenetics for monitoring patients with chronic myeloid leukemia during early phase of imatinib therapy. Leukemia 2004; 89: 49-57. Haematologica 2004;89(8):ELT12-ELT12; https://doi.org/10.3324/%x.